|
1
|
Wang W, Liu Z, Zhao L, Sun J, He Q, Yan W,
Lu Z and Wang A: Hexokinase 2 enhances the metastatic potential of
tongue squamous cell carcinoma via the
SOD2-H2O2pathway. Oncotarget. 8:3344–3354.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Rosebush MS, Rao SK, Samant S, Gu W,
Handorf CR, Pfeffer LM and Nosrat CA: Oral cancer: Enduring
characteristics and emerging trends. J Mich Dent Assoc. 94:64–68.
2012.PubMed/NCBI
|
|
3
|
Chen C, Méndez E, Houck J, Fan W,
Lohavanichbutr P, Doody D, Yueh B, Futran ND, Upton M, Farwell DG,
et al: Gene expression profiling identifies genes predictive of
oral squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev.
17:2152–2162. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Fang Z, Wu L, Wang L, Yang Y, Meng Y and
Yang H: Increased expression of the long non-coding RNA UCA1 in
tongue squamous cell carcinomas: A possible correlation with cancer
metastasis. Oral Surg Oral Med Oral Pathol Oral Radiol. 117:89–95.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Valencia-Sanchez MA, Liu J, Hannon GJ and
Parker R: Control of translation and mRNA degradation by miRNAs and
siRNAs. Genes Dev. 20:515–524. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Pillai RS, Bhattacharyya SN and Filipowicz
W: Repression of protein synthesis by miRNAs: How many mechanisms?
Trends Cell Biol. 17:118–126. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yu J, Ryan DG, Getsios S,
Oliveira-Fernandes M, Fatima A and Lavker RM: MicroRNA-184
antagonizes microRNA-205 to maintain SHIP2 levels in epithelia.
Proc Natl Acad Sci USA. 105:19300–19305. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ambros V: The functions of animal
microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tung MC, Lin PL, Cheng YW, Wu DW, Yeh SD,
Chen CY and Lee H: Reduction of microRNA-184 by E6 oncoprotein
confers cisplatin resistance in lung cancer via increasing Bcl-2.
Oncotarget. 7:32362–32374. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Emdad L, Janjic A, Alzubi MA, Hu B,
Santhekadur PK, Menezes ME, Shen XN, Das SK, Sarkar D and Fisher
PB: Suppression of miR-184 in malignant gliomas upregulates SND1
and promotes tumor aggressiveness. Neuro Oncol. 17:419–429. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Foley NH, Bray IM, Tivnan A, Bryan K,
Murphy DM, Buckley PG, Ryan J, O'Meara A, O'Sullivan M and
Stallings RL: MicroRNA-184 inhibits neuroblastoma cell survival
through targeting the serine/threonine kinase AKT2. Mol Cancer.
9:832010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhen Y, Liu Z, Yang H, Yu X, Wu Q, Hua S,
Long X, Jiang Q, Song Y, Cheng C, et al: Tumor suppressor PDCD4
modulates miR-184-mediated direct suppression of C-MYC and BCL2
blocking cell growth and survival in nasopharyngeal carcinoma. Cell
Death Dis. 4:e8722013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wu GG, Li WH, He WG, Jiang N, Zhang GX,
Chen W, Yang HF, Liu QL, Huang YN, Zhang L, et al: Mir-184
post-transcriptionally regulates SOX7 expression and promotes cell
proliferation in human hepatocellular carcinoma. PLoS One.
9:e887962014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wong TS, Liu XB, Wong BY, Ng RW, Yuen AP
and Wei WI: Mature miR-184 as potential oncogenic microRNA of
squamous cell carcinoma of tongue. Clin Cancer Res. 14:2588–2592.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lefebvre V, Dumitriu B, Penzo-Méndez A,
Han Y and Pallavi B: Control of cell fate and differentiation by
Sry-related high-mobility-group box (Sox) transcription factors.
Int J Biochem Cell Biol. 39:2195–2214. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Liu H, Mastriani E, Yan ZQ, Yin SY, Zeng
Z, Wang H, Li QH, Liu HY, Wang X, Bao HX, et al: SOX7 co-regulates
Wnt/β-catenin signaling with Axin-2: Both expressed at low levels
in breast cancer. Sci Rep. 6:261362016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Harley VR, Lovell-Badge R and Goodfellow
PN: Definition of a consensus DNA binding site for SRY. Nucleic
Acids Res. 22:1500–1501. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Stovall DB, Cao P and Sui G: SOX7: From a
developmental regulator to an emerging tumor suppressor. Histol
Histopathol. 29:439–445. 2014.PubMed/NCBI
|
|
19
|
Zheng Z, Liu J, Yang Z, Wu L, Xie H, Jiang
C, Lin B, Chen T, Xing C, Liu Z, et al: MicroRNA-452 promotes
stem-like cells of hepatocellular carcinoma by inhibiting Sox7
involving Wnt/β-catenin signaling pathway. Oncotarget.
7:28000–28012. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yu X and Li Z: MicroRNA expression and its
implications for diagnosis and therapy of tongue squamous cell
carcinoma. J Cell Mol Med. 20:10–16. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Calin GA and Croce CM: MicroRNA signatures
in human cancers. Nat Rev Cancer. 6:857–866. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Shiomi N, Mori M, Tsuji H, Imai T, Inoue
H, Tateishi S, Yamaizumi M and Shiomi T: Human RAD18 is involved in
S phase-specific single-strand break repair without PCNA
monoubiquitination. Nucleic Acids Res. 35:e92007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Deng J, He M, Chen L, Chen C, Zheng J and
Cai Z: The loss of miR-26a-mediated post-transcriptional regulation
of cyclin E2 in pancreatic cancer cell proliferation and decreased
patient survival. PLoS One. 8:e764502013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Shen F, Cai WS, Feng Z, Li JL, Chen JW,
Cao J and Xu B: MiR-492 contributes to cell proliferation and cell
cycle of human breast cancer cells by suppressing SOX7 expression.
Tumour Biol. 36:1913–1921. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Liu H, Yan ZQ, Li B, Yin SY, Sun Q, Kou
JJ, Ye D, Ferns K, Liu HY and Liu SL: Reduced expression of SOX7 in
ovarian cancer: A novel tumor suppressor through the Wnt/β-catenin
signaling pathway. J Ovarian Res. 7:872014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yang M, Cui G, Ding M, Yang W, Liu Y, Dai
D and Chen L: miR-935 promotes gastric cancer cell proliferation by
targeting SOX7. Biomed Pharmacother. 79:153–158. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Man CH, Fung TK, Wan H, Cher CY, Fan A, Ng
N, Ho C, Wan TS, Tanaka T, So CW, et al: Suppression of SOX7 by DNA
methylation and its tumor suppressor function in acute myeloid
leukemia. Blood. 125:3928–3936. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Schepers GE, Teasdale RD and Koopman P:
Twenty pairs of sox: Extent, homology, and nomenclature of the
mouse and human sox transcription factor gene families. Dev Cell.
3:167–170. 2002. View Article : Google Scholar : PubMed/NCBI
|
